Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBDex is the pharmaceutical brand of Cannabis Pharma, s.r.o., a Czech biotechnology company specializing in the development and manufacture of cannabinoid-based therapies. Founded in 2002, the company focuses on high-purity cannabidiol (CBD) formulations for a variety of medical applications, including neurology, psychiatry, and dermatology. Their product line includes medical devices, such as nasal sprays and inhalation solutions, as well as dietary supplements designed to support the endocannabinoid system. CBDex emphasizes pharmaceutical-grade production standards and has established a significant presence in the European cannabinoid market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBDex Pharmaceuticals.